抗中性人细胞质抗体相关血管炎的疾病异质性:对治疗方法的影响

Julia A Ford1, Paul A Monach2

  • 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

The Lancet. Rheumatology
|January 17, 2024
PubMed
概括

与抗中性细胞体抗体 (ANCA) 相关的血管炎现在可以治疗,但由于疾病异质性,治疗有所不同. 了解这些差异是有效的ANCA血管炎管理和未来研究的关键.